Results 191 to 200 of about 175,800 (301)

Strategic delegation and risk‐taking in R&D: Partial delegation versus full delegation

open access: yesInternational Journal of Economic Theory, Volume 22, Issue 2, Page 183-207, June 2026.
Abstract We examine firm's risk‐taking decisions in R&D under two different delegation strategies between partial delegation (PD) and full delegation (FD): FD authorizes both quantity and R&D risk but PD only authorizes quantity. Cournot firms under the FD set higher profit weights at the expected value of cost realization, which can lessen competition,
Mingqing Xing, Sang‐Ho Lee
wiley   +1 more source

Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma

open access: yesLiver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims To evaluate the prognostic significance of pathological response in patients with initially unresectable hepatocellular carcinoma (uHCC) who underwent salvage resection after successful conversion with lenvatinib, anti‐PD‐1 antibodies, and locoregional therapy (LPLRT).
Qi‐Yu Chi   +9 more
wiley   +1 more source

Development and validation of a high-confidence diagnostic model integrating ctDNA methylation and serum biomarkers for early-stage hepatocellular carcinoma detection. [PDF]

open access: yesMol Biomed
Wu H   +16 more
europepmc   +1 more source

Delegates to the AFPE

open access: yesAmerican Journal of Pharmaceutical Education, 1956
openaire   +1 more source

From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC?

open access: yesLiver International, Volume 46, Issue 6, June 2026.
ABSTRACT Systemic therapies for advanced hepatocellular carcinoma (HCC) have expanded considerably with the advent of tyrosine kinase inhibitors, immune checkpoint inhibitors and immunotherapy–anti‐angiogenic combinations. However, despite this therapeutic diversification, first‐line treatment selection remains largely empirical, as few biomarkers are ...
Marie Decraecker   +3 more
wiley   +1 more source

Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry

open access: yesLiver International, Volume 46, Issue 6, June 2026.
ABSTRACT Evidence supporting the safety and efficacy of immune checkpoint inhibitors (ICI) before liver transplantation (LTx) in hepatocellular carcinoma (HCC) is increasing, but risks of graft rejection and tumour recurrence remain major concerns. We evaluated post‐transplant outcomes across 10 European centres using data from the multinational LITCHI
Ulrike Bauer   +22 more
wiley   +1 more source

Long-Term Survival After Desperation Surgery for Primary Mediastinal Non-Seminomatous Germ Cell Tumor With Rising Alpha-Fetoprotein. [PDF]

open access: yesIJU Case Rep
Aigase T   +9 more
europepmc   +1 more source

Reversing Fatigue Damage in Carbon Fiber–Thermoplastic Composites Using Localized Plasma Heating

open access: yesPolymer Composites, Volume 47, Issue 10, Page 8990-9001, 20 May 2026.
Schematic overview of the plasma‐assisted repair strategy for fatigue‐damaged short fiber carbon fiber/ABS composites. Pristine specimens are subjected to cyclic fatigue loading inducing damage. Localized plasma heating softens the thermoplastic matrix, enabling healing and restoring mechanical performance. Tensile testing is used to quantify recovery.
Hung Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy